Re-resection for isolated local recurrence of pancreatic cancer is feasible, safe, and associated with encouraging survival

• Verfasst von: Strobel, Oliver [VerfasserIn]
• Verfasst von: Hartwig, Werner [VerfasserIn]
• Verfasst von: Hackert, Thilo [VerfasserIn]
• Verfasst von: Hinz, Ulf [VerfasserIn]
• Verfasst von: Berens, Viktoria [VerfasserIn]
• Verfasst von: Grenacher, Lars [VerfasserIn]
• Verfasst von: Bergmann, Frank [VerfasserIn]
• Verfasst von: Debus, Jürgen [VerfasserIn]
• Verfasst von: Jäger, Dirk [VerfasserIn]
• Verfasst von: Büchler, Markus W. [VerfasserIn]
• Verfasst von: Werner, Jens [VerfasserIn]
• Titel: Re-resection for isolated local recurrence of pancreatic cancer is feasible, safe, and associated with encouraging survival
• Verf.angabe: Oliver Strobel, MD, Werner Hartwig, MD,Thilo Hackert, MD, Ulf Hinz, MSc, Viktoria Berens, MD, Lars Grenacher, MD, Frank Bergmann, MD, Jürgen Debus, MD, Dirk Jäger, MD, Markus Büchler, MD, and Jens Werner, MD
• Jahr: 2013
• Jahr des Originals: 2012
• Umfang: 9 S.
• Fussnoten: Published online: 12 December 2012 ; Gesehen am 25.08.2020
• Titel Quelle: Enthalten in: Annals of surgical oncology
• Ort Quelle: Berlin [u.a.] : Springer, 1994
• Jahr Quelle: 2013
• Band/Heft Quelle: 20(2013), 3, Seite 964-972
• ISSN Quelle: 1534-4681
• DOI: doi:10.1245/s10434-012-2762-z
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 1574995316

Abstract

BackgroundLocal recurrence of pancreatic cancer occurs in 80 % of patients within 2 years after potentially curative resections. Around 30 % of patients have isolated local recurrence (ILR) without evidence of metastases. In spite of localized disease these patients usually only receive palliative chemotherapy and have a short survival.PurposeTo evaluate the outcome of surgery as part of a multimodal treatment for ILR of pancreatic cancer.MethodsAll consecutive operations performed for suspected ILR in our institution between October 2001 and October 2009 were identified from a prospective database. Perioperative outcome, survival, and prognostic parameters were assessed.ResultsOf 97 patients with histologically proven recurrence, 57 (59 %) had ILR. In 40 (41 %) patients surgical exploration revealed metastases distant to the local recurrence. Resection was performed in 41 (72 %) patients with ILR, while 16 (28 %) ILR were locally unresectable. Morbidity and mortality were 25 and 1.8 % after resections and 10 and 0 % after explorations, respectively. Median postoperative survival was 16.4 months in ILR versus 9.4 months in metastatic disease (p < 0.0001). In ILR median survival was significantly longer after resection (26.0 months) compared with exploration without resection (10.8 months, p = 0.0104). R0 resection was achieved in 18 patients and resulted in 30.5 months median survival. Presence of metastases, incomplete resection, and high preoperative CA 19-9 serum values were associated with lesser survival.ConclusionsResection for isolated local recurrence of pancreatic cancer is feasible, safe, and associated with favorable survival outcome. This concept warrants further evaluation in other institutions and in randomized controlled trials.